Samyang Holdings Corporation
About Samyang Holdings Corporation
Certifications
Categories
-
KR
-
2022On CPHI since
-
2Certificates
-
500 - 999Employees
Company types
Primary activities
Meet us at
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Products from Samyang Holdings Corporation (3)
-
Product FPFs
• Genexol®PM Inj.(Paclitaxel) • Genexol® Inj.(Paclitaxel) • Nanoxel®M Inj.(Docetaxel) • Docetaxel Inj.(Docetaxel) • Nexatin® Inj.(Oxaliplatin) • Everose® Tab.(Everolimus) • Pemed®S Inj.(Pemetrexed) • Azalid® Inj.(Azacitidine) • Decilid® Inj.(Decitabine) • Lenalid® Inj.(Lenalid... -
Product APIs
• Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request) -
Product CDMO
• Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY • CYTOTOXIC API • EU GMP • JGMP (Japan) • KGMP (Korea) • PIC/S
Samyang Holdings Corporation Resources (1)
-
Brochure Samyang Holdings Corporation_Brochure
Product portfolio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance